|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 144.88 USD | +0.44% |
|
+2.42% | -11.58% |
| 07-07 | Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185 | MT |
| 06-29 | Repligen Corporation(NasdaqGS:RGEN) dropped from Russell Small Cap Comp Growth Benchmark | CI |
Company Valuation: Repligen Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,643 | 9,401 | 10,039 | 8,064 | 9,224 | 8,172 | - | - |
| Change | - | -35.8% | 6.78% | -19.67% | 14.38% | -11.4% | - | - |
| Enterprise Value (EV) 1 | 14,405 | 9,062 | 9,357 | 7,833 | 9,200 | 7,918 | 7,740 | 7,524 |
| Change | - | -37.09% | 3.26% | -16.29% | 17.46% | -13.94% | -2.24% | -2.8% |
| P/E | 118x | 52.3x | 243x | -313x | 191x | 133x | 80.7x | 57.3x |
| PBR | 8.67x | 4.92x | 5.09x | 4.09x | 4.38x | 3.72x | 3.48x | 3.15x |
| PEG | - | 1.2x | -3.1x | 2x | -1x | 5x | 1.2x | 1.4x |
| Capitalization / Revenue | 21.8x | 11.7x | 15.7x | 12.7x | 12.5x | 9.98x | 8.66x | 7.52x |
| EV / Revenue | 21.5x | 11.3x | 14.6x | 12.3x | 12.5x | 9.67x | 8.21x | 6.92x |
| EV / EBITDA | 62.5x | 36.7x | 73.1x | 66.8x | 65.6x | 47.1x | 37.4x | 29.2x |
| EV / EBIT | 66.9x | 39x | 99.2x | 95.4x | 90.4x | 62x | 46.3x | 34.7x |
| EV / FCF | 277x | 104x | 120x | 52.3x | 98x | 64.4x | 52.1x | 38.1x |
| FCF Yield | 0.36% | 0.96% | 0.83% | 1.91% | 1.02% | 1.55% | 1.92% | 2.62% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.24 | 3.24 | 0.74 | -0.46 | 0.86 | 1.089 | 1.796 | 2.53 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 670.5 | 801.5 | 638.8 | 634.4 | 738.3 | 818.5 | 943.3 | 1,087 |
| EBITDA 1 | 230.5 | 246.9 | 128 | 117.3 | 140.3 | 167.9 | 207.2 | 257.7 |
| EBIT 1 | 215.2 | 232.2 | 94.29 | 82.08 | 101.8 | 127.7 | 167.2 | 216.9 |
| Net income 1 | 128.3 | 186 | 41.58 | -25.51 | 48.89 | 61.05 | 101.2 | 143.8 |
| Net Debt 1 | -237.8 | -339.1 | -681.9 | -231.8 | -23.81 | -254.4 | -431.9 | -648.7 |
| Reference price 2 | 264.84 | 169.31 | 179.80 | 143.94 | 163.86 | 144.88 | 144.88 | 144.88 |
| Nbr of stocks (in thousands) | 55,289 | 55,524 | 55,832 | 56,027 | 56,291 | 56,408 | - | - |
| Announcement Date | 2/17/22 | 2/22/23 | 2/21/24 | 2/20/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 133.05x | 9.67x | 47.15x | -.--% | 8.17B | |
| 22.78x | 3.43x | 12.77x | 2.76% | 160B | |
| 18.94x | 3.3x | 11.63x | 3.55% | 107B | |
| 17.03x | 0.19x | 12.02x | 0.77% | 59.56B | |
| 32.21x | 7.82x | 20.43x | 1.25% | 52.51B | |
| 38.33x | 3.04x | 10.43x | 2.5% | 42.39B | |
| 38.9x | 1.41x | 12.41x | 0.2% | 34.31B | |
| 31.19x | 5.56x | 17.73x | -.--% | 29.46B | |
| 42.74x | 7.47x | 26.97x | 0.24% | 25.41B | |
| 23.88x | 3.49x | 12.54x | 1.21% | 21.15B | |
| Average | 39.91x | 4.54x | 18.41x | 1.25% | 54.04B | |
| Weighted average by Cap. | 27.66x | 3.72x | 14.45x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RGEN Stock
- Valuation Repligen Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
